1. Home
  2. CGON vs CVI Comparison

CGON vs CVI Comparison

Compare CGON & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • CVI
  • Stock Information
  • Founded
  • CGON 2010
  • CVI 1906
  • Country
  • CGON United States
  • CVI United States
  • Employees
  • CGON N/A
  • CVI N/A
  • Industry
  • CGON
  • CVI Integrated oil Companies
  • Sector
  • CGON
  • CVI Energy
  • Exchange
  • CGON NYSE
  • CVI Nasdaq
  • Market Cap
  • CGON 2.3B
  • CVI 1.9B
  • IPO Year
  • CGON 2024
  • CVI 2007
  • Fundamental
  • Price
  • CGON $27.85
  • CVI $20.34
  • Analyst Decision
  • CGON Strong Buy
  • CVI Sell
  • Analyst Count
  • CGON 10
  • CVI 5
  • Target Price
  • CGON $65.11
  • CVI $23.00
  • AVG Volume (30 Days)
  • CGON 430.1K
  • CVI 909.3K
  • Earning Date
  • CGON 03-04-2025
  • CVI 02-18-2025
  • Dividend Yield
  • CGON N/A
  • CVI 7.37%
  • EPS Growth
  • CGON N/A
  • CVI N/A
  • EPS
  • CGON N/A
  • CVI 0.07
  • Revenue
  • CGON $684,000.00
  • CVI $7,610,000,000.00
  • Revenue This Year
  • CGON $158.34
  • CVI N/A
  • Revenue Next Year
  • CGON N/A
  • CVI N/A
  • P/E Ratio
  • CGON N/A
  • CVI $292.17
  • Revenue Growth
  • CGON 258.12
  • CVI N/A
  • 52 Week Low
  • CGON $25.77
  • CVI $15.60
  • 52 Week High
  • CGON $47.78
  • CVI $38.07
  • Technical
  • Relative Strength Index (RSI)
  • CGON 41.49
  • CVI 57.98
  • Support Level
  • CGON $27.10
  • CVI $18.91
  • Resistance Level
  • CGON $29.42
  • CVI $22.20
  • Average True Range (ATR)
  • CGON 1.15
  • CVI 0.93
  • MACD
  • CGON -0.10
  • CVI 0.13
  • Stochastic Oscillator
  • CGON 29.02
  • CVI 58.67

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. subsidiaries include several complex full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: